Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Secondary prevention

Citations 261-270 of 568 total displayed.

Past content (since Feb 1999):

Coronary Heart Disease
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:1406-1412; published online before print as doi:10.1161/01.CIR.0000141728.23033.B5 [Abstract] [Full text]  

Heart Failure
Predictors of Heart Failure Among Women With Coronary Disease
Kirsten Bibbins-Domingo, Feng Lin, Eric Vittinghoff, Elizabeth Barrett-Connor, Stephen B. Hulley, Deborah Grady, and Michael G. Shlipak
Circulation 2004;110:1424-1430; published online before print as doi:10.1161/01.CIR.0000141726.01302.83 [Abstract] [Full text]  

Articles
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
Marcello Tonelli, Chris Isles, Gary C. Curhan, Andrew Tonkin, Marc A. Pfeffer, James Shepherd, Frank M. Sacks, Curt Furberg, Stuart M. Cobbe, John Simes, Timothy Craven, and Malcolm West
Circulation published September 13, 2004, doi:10.1161/01.CIR.0000143892.84582.60 [Abstract]  

Articles
Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries
Clemens von Birgelen, Marc Hartmann, Gary S. Mintz, K. Gert van Houwelingen, Nadine Deppermann, Axel Schmermund, Dirk Böse, Holger Eggebrecht, Till Neumann, Mario Gössl, Heinrich Wieneke, and Raimund Erbel
Circulation published September 13, 2004, doi:10.1161/01.CIR.0000142048.94084.CA [Abstract]  

Articles
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000141728.23033.B5 [Abstract]  

Articles
Predictors of Heart Failure Among Women With Coronary Disease
Kirsten Bibbins-Domingo, Feng Lin, Eric Vittinghoff, Elizabeth Barrett-Connor, Stephen B. Hulley, Deborah Grady, and Michael G. Shlipak
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000141726.01302.83 [Abstract]  

Coronary Heart Disease
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Donald E. Cutlip, Amit G. Chhabra, Donald S. Baim, Manish S. Chauhan, Sachin Marulkar, Joseph Massaro, Ameet Bakhai, David J. Cohen, Richard E. Kuntz, and Kalon K.L. Ho
Circulation 2004;110:1226-1230; published online before print as doi:10.1161/01.CIR.0000140721.27004.4B [Abstract] [Full text]  

Coronary Heart Disease
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Julia Critchley, Jing Liu, Dong Zhao, Wang Wei, and Simon Capewell
Circulation 2004;110:1236-1244; published online before print as doi:10.1161/01.CIR.0000140668.91896.AE [Abstract] [Full text]  

ACC/AHA Guideline Update
ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery)
Kim A. Eagle, Robert A. Guyton, Ravin Davidoff, Fred H. Edwards, Gordon A. Ewy, Timothy J. Gardner, James C. Hart, Howard C. Herrmann, L. David Hillis, Adolph M. Hutter, Jr, Bruce Whitney Lytle, Robert A. Marlow, William C. Nugent, Thomas A. Orszulak, Elliott M. Antman, Sidney C. Smith, Jr, Joseph S. Alpert, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, and Joseph P. Ornato
Circulation 2004;110:1168-1176, doi:10.1161/01.CIR.0000138790.14877.7D [Full text]  

Articles
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Julia Critchley, Jing Liu, Dong Zhao, Wang Wei, and Simon Capewell
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140668.91896.AE [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

* Subspecialty Collections Home

* Show  Secondary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment